Barinthus Biotherapeutics plc (FRA:2AB)

Germany · Delayed Price · Currency is EUR

0.6200

+0.0300 (5.08%)

Last updated: Jan 9, 2026, 8:02 AM CET

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Immunotherapies and Vaccines	14.97M	Log In	Log In	Log In	Log In	Upgrade
Immunotherapies and Vaccines Growth	1766.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United Kingdom	14.97M	Log In	Log In	Log In	Log In	Upgrade
United Kingdom and United States	-	Log In	Log In	Log In	Log In	Upgrade
United Kingdom and United States Growth	-	Log In	Log In	Log In	Log In	Upgrade